Minakem has initiated an ambitious investment plan for setting up equipments with the highest level of containment required to develop and produce highly potent molecules such as Antibody-drug conjugates toxins. The investments will enable Minakem to handle High Potent API (HAPI) with an OEL lower than 0.1 µg/m³.8h.